Herbalife Ltd. Files Q3 2024 10-Q Report

Ticker: HLF · Form: 10-Q · Filed: Oct 30, 2024 · CIK: 1180262

Herbalife LTD. 10-Q Filing Summary
FieldDetail
CompanyHerbalife LTD. (HLF)
Form Type10-Q
Filed DateOct 30, 2024
Risk Levelmedium
Pages15
Reading Time18 min
Key Dollar Amounts$0.0005
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, herbalife

TL;DR

**Herbalife Q3 2024 10-Q is in. Check financials.**

AI Summary

Herbalife Ltd. filed its 10-Q for the period ending September 30, 2024. The filing details the company's financial performance and operations. Key financial information and operational updates are provided for the third quarter of 2024.

Why It Matters

This filing provides investors and analysts with the latest financial performance data for Herbalife Ltd., crucial for understanding the company's current health and future prospects.

Risk Assessment

Risk Level: medium — As a publicly traded company, Herbalife Ltd. is subject to market fluctuations and regulatory scrutiny, making its risk level medium.

Key Numbers

Key Players & Entities

FAQ

What is the filing date of this 10-Q report?

The filing date of this 10-Q report for Herbalife Ltd. is October 30, 2024.

What is the reporting period covered by this 10-Q?

This 10-Q report covers the period ending September 30, 2024.

What is Herbalife Ltd.'s Central Index Key (CIK)?

Herbalife Ltd.'s Central Index Key (CIK) is 0001180262.

What is the company's SIC code?

The Standard Industrial Classification (SIC) code for Herbalife Ltd. is 5122, which corresponds to Wholesale-Drugs Proprietaries & Druggists' Sundries.

What was the previous name of Herbalife Ltd. and when did it change?

Herbalife Ltd. was formerly known as HERBALIFE NUTRITION LTD. and changed its name on April 24, 2018.

Filing Stats: 4,399 words · 18 min read · ~15 pages · Grade level 10 · Accepted 2024-10-30 16:18:35

Key Financial Figures

Filing Documents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements 3 Unaudited Condensed Consolidated Balance Sheets 3 Unaudited Condensed Consolidated Statements of Income 4 Unaudited Condensed Consolidated Statements of Comprehensive (Loss) Income 5 Unaudited Condensed Consolidated Statements of Cash Flows 6 Notes to Unaudited Condensed Consolidated Financial Statements 7 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 37 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 58 Item 4.

Controls and Procedures

Controls and Procedures 62

OTHER INFORMATION

PART II. OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 65 Item 1A.

Risk Factors

Risk Factors 65 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 65 Item 3. Defaults Upon Senior Securities 65 Item 4. Mine Safety Disclosures 65 Item 5. Other Information 65 Item 6. Exhibits 65 2

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements HERBALIFE LTD. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) September 30, 2024 December 31, 2023 (in millions, except share and par value amounts) ASSETS Current assets: Cash and cash equivalents $ 402.5 $ 575.2 Receivables, net of allowance for doubtful accounts 82.0 81.2 Inventories 515.3 505.2 Prepaid expenses and other current assets 244.8 237.7 Total current assets 1,244.6 1,399.3 Property, plant, and equipment, at cost, net of accumulated depreciation and amortization 463.3 506.5 Operating lease right-of-use assets 187.7 185.8 Marketing-related intangibles and other intangible assets, net 312.7 314.0 Goodwill 93.1 95.4 Other assets 352.1 308.4 Total assets $ 2,653.5 $ 2,809.4 LIABILITIES AND SHAREHOLDERS' DEFICIT Current liabilities: Accounts payable $ 86.6 $ 84.0 Royalty overrides 332.1 343.4 Current portion of long-term debt 283.3 309.5 Other current liabilities 583.0 540.7 Total current liabilities 1,285.0 1,277.6 Long-term debt, net of current portion 1,977.9 2,252.9 Non-current operating lease liabilities 167.3 167.6 Other non-current liabilities 177.5 171.6 Total liabilities 3,607.7 3,869.7 Commitments and contingencies Shareholders' deficit: Common shares, $ 0.0005 par value; 2.0 billion shares authorized; 100.7 million (2024) and 99.2 million (2023) shares outstanding 0.1 0.1 Paid-in capital in excess of par value 267.0 233.9 Accumulated other comprehensive loss ( 235.4 ) ( 232.0 ) Accumulated deficit ( 985.9 ) ( 1,062.3 ) Total shareholders' deficit ( 954.2 ) ( 1,060.3 ) Total liabilities and shareholders' deficit $ 2,653.5 $ 2,809.4 See the accompanying notes to unaudited condensed consolidated financial statements. 3 HERBALIFE LTD. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF IN

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing